Mochida Pharmaceutical Co., Ltd., and Siemens K.K. Japan have agreed to change the ownership interest both companies hold in their joint venture. Mochida Siemens Medical Systems Co., Ltd. Today, Mochida Pharmaceutical transferred 16 percent of its outstanding shares to Siemens K.K., making
Siemens K.K. a 51 percent equity stakeholder. The share transfer means that Mochida Siemens Medical Systems Co., Ltd. will become a fully consolidated subsidiary of Siemens and an equity-consolidated affiliate of Mochida Pharmaceutical Co., Ltd.

The joint venture

«« Boston Scientific Announces Approval of New Cardiac Devices


ESC Congress 2007 Builds on its Success »»


Latest Articles

Mochida Pharmaceutical Co., Ltd., and Siemens K.K. Japan have agreed to change the ownership interest both companies hold in their joint venture. Mochida...